Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04550429 · ClinicalTrials.gov registry record · NA
Uterine Filling Pressure in Hysteroscopy
A NA study, sponsored by Northwestern University.
- Terminated
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT04550429 is a NA study that was terminated before completion, run by Northwestern University. The registered enrollment target is 35 participants.
The verdict
NCT04550429, a NA study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The aim of the study is to compare the outcomes of patients undergoing hysteroscopy with a MyoSure device with a pressure of 60 mmHg to those using the standard of 80 mmHg.
Interventions
- DEVICE MyoSure Hysteroscopic Morcellator Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2020-08-21 |
| Est. Completion | 2023-09-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04550429
The ClinicalTrials.gov registry entry for NCT04550429 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MyoSure Hysteroscopic Morcellator Device is the first listed.
NCT04550429 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04550429 about?
NCT04550429 is a clinical study titled "Uterine Filling Pressure in Hysteroscopy". The aim of the study is to compare the outcomes of patients undergoing hysteroscopy with a MyoSure device with a pressure of 60 mmHg to those using the standard of 80 mmHg.
What is the current status of trial NCT04550429?
This trial is currently terminated. It is a NA study. The enrollment target is 35 participants. The study started on 2020-08-21. Estimated completion is 2023-09-11.
What interventions are being tested in trial NCT04550429?
The interventions under investigation include: MyoSure Hysteroscopic Morcellator Device (DEVICE).
Who is sponsoring clinical trial NCT04550429?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.